spire trial: overcoming cisplatin resistance in bladder cancer with transcriptome changes
Published 5 years ago • 140 plays • Length 1:26Download video MP4
Download video MP3
Similar videos
-
1:47
current and upcoming clinical trials in bladder cancer
-
1:25
phase ii study of neoadjuvant atezolizumab with gemcitabine and cisplatin in patients with mibc
-
1:23
how effective is pembrolizumab in cisplatin-ineligible bladder cancer? results from keynote-052
-
7:45
phase-2 trial of gemcitabine, cisplatin nivolumab with selective bladder sparing in mibc patients
-
2:15
blasst-1: nivolumab gemcitabine-cisplatin before radical cystectomy in muscle-invasive bc
-
3:52
trial updates from asco gu 2021: spire, neo-blade, p3bep and saprocan
-
2:26
niagara: perioperative durvalumab with neoadjuvant chemotherapy in mibc
-
4:21
coach trial update: gemox vs. gcb in cisplatin-unfit advanced urothelial carcinoma
-
8:08
gene mutations as predictive biomarkers for cisplatin-based chemotherapy response in bladder cancer
-
1:17
borealis-1™: phase 2 trial of gemcitabine/cisplatin plus apatorsen in advanced bladder cancer
-
1:22
key clinical trials in urothelial carcinoma at esmo 2021
-
1:29
biscay trial for bladder cancer - trial design and its potential impact on clinical practice
-
2:58
ev-201: enfortumab vedotin for cisplatin-ineligible bladder cancer
-
1:02
a randomized trial of photodynamic surgery in non–muscle-invasive bladder cancer
-
1:27
a promising future for gemcitabine-oxaliplatin in cisplatin-unfit advanced urothelial carcinoma
-
7:24
hcrn gu 16-257: phase 2 trial of gemcitabine, cisplatin, plus nivolumab with selective bladder s...
-
1:23
bladder cancer research at esmo 2021
-
3:46
perioperative management of advanced bladder cancer